These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 9835153

  • 21. [The prevalence of hepatitis A, B and C viral markers in the population of Gijón between 26 and 65 years old].
    Suárez A, Viejo G, Navascués CA, García R, Díaz G, Saro C, Román FJ.
    Gastroenterol Hepatol; 1997; 20(7):347-52. PubMed ID: 9377232
    [Abstract] [Full Text] [Related]

  • 22. [High prevalence of hepatitis B and C markers in an indigent community in Caracas, Venezuela].
    Ponce JG, Cadenas LF, García F, León G, Blitz-Dorfman L, Monsalve F, Pujol FH.
    Invest Clin; 1994 Sep; 35(3):123-9. PubMed ID: 7803548
    [Abstract] [Full Text] [Related]

  • 23. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Sep; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 24. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
    Tsatsralt-Od B, Takahashi M, Nishizawa T, Inoue J, Ulaankhuu D, Okamoto H.
    Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
    [Abstract] [Full Text] [Related]

  • 25. [Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria].
    Ayed Z, Houinato D, Hocine M, Ranger-Rogez S, Denis F.
    Bull Soc Pathol Exot; 1995 Apr; 88(5):225-8. PubMed ID: 8646011
    [Abstract] [Full Text] [Related]

  • 26. Seroprevalence and risk factors for hepatitis A, B, and C among Roma and non-Roma children in a deprived area of Athens, Greece.
    Michos A, Terzidis A, Kalampoki V, Pantelakis K, Spanos T, Petridou ET.
    J Med Virol; 2008 May; 80(5):791-7. PubMed ID: 18360892
    [Abstract] [Full Text] [Related]

  • 27. [Prevalence of markers of hepatitis B infection in the adult population of the district of Coimbra].
    Santos A, Carvalho A, Tomaz J, Rodrigues V, Coxinho L, Bento D, Sá R, Porto A.
    Acta Med Port; 2000 May; 13(4):167-71. PubMed ID: 11155483
    [Abstract] [Full Text] [Related]

  • 28. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey.
    Nascimento MC, Mayaud P, Sabino EC, Torres KL, Franceschi S.
    J Med Virol; 2008 Jan; 80(1):53-7. PubMed ID: 18041005
    [Abstract] [Full Text] [Related]

  • 29. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, Keles H.
    Ren Fail; 2006 Jan; 28(8):729-35. PubMed ID: 17162434
    [Abstract] [Full Text] [Related]

  • 30. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
    Said ZN, El-Sayed MH, El-Bishbishi IA, El-Fouhil DF, Abdel-Rheem SE, El-Abedin MZ, Salama II.
    Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Prevalence of hepatitis B and C virus markers among medical staff at a third-level hospital].
    Vivas Arceo C, Torres Garibay JC, Aguilar Benavides S.
    Rev Gastroenterol Mex; 1997 Apr; 62(2):108-12. PubMed ID: 9471660
    [Abstract] [Full Text] [Related]

  • 33. Prevalence of hepatitis C virus among patients with liver disease in the Republic of Yemen.
    Al-Moslih MI, Al-Huraibi MA.
    East Mediterr Health J; 2001 Apr; 7(4-5):771-8. PubMed ID: 15332778
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
    Loras C, Saro C, Gonzalez-Huix F, Mínguez M, Merino O, Gisbert JP, Barrio J, Bernal A, Gutiérrez A, Piqueras M, Calvet X, Andreu M, Abad A, Ginard D, Bujanda L, Panés J, Torres M, Fernández-Bañares F, Viver JM, Esteve M, GETECCu (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa).
    Am J Gastroenterol; 2009 Jan; 104(1):57-63. PubMed ID: 19098850
    [Abstract] [Full Text] [Related]

  • 37. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Aoufi S, Pascasio JM, Sousa JM, Sayago M, Ferrer MT, Gómez-Delgado E, De la Cruz MD, Alamo JM, Gómez-Bravo MA, Bernardos A, Márquez JL.
    Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prevalence of markers of hepatotropic viruses A, B, C and the efficacy of vaccination against hepatitis A and hepatitis B among medical students.
    Jabłkowski M, Kuydowicz J, Strzelczyk J, Białkowska J.
    Med Sci Monit; 2002 Nov; 8(11):CR762-6. PubMed ID: 12444381
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.